Formulation and characterization of levofloxacin-loaded biodegradable nanoparticles
Main Article Content
Abstract
levofloxacin as potential ophthalmic drug delivery system.The levofloxacin-loaded chitosan nanoparticles were prepared by ionic gelation of chitosan with tripolyphosphate anions.The nanoparticles were characterized by scanning electron microscopy, zeta potential analyzer, differential scanning calorimetry, and fourier transform infrared spectroscopy. All the prepared formulations resulted in nano-range size particles (317–501 nm) and displayed spherical smooth morphology with zeta potential (+37.2 to +43.5 mV).The encapsulation efficiency and loading capacity were 65–83% and 15–25%, respectively. The levofloxacin-loaded chitosan nanoparticles displayed more crystallinity than levofloxacin. The in vitro diffusion profile of levofloxacin from the nanoparticles showed a sustained release of the drug over a period of 20 h. Kinetic release profiles of levofloxacin from nanoparticles appeared to fit best with Higuchi model with zero order and the non-Fickian diffusion was superior phenomenon. Thus, the results suggest that levofloxacin-loaded chitosan nanoparticle suspension appears to
be promising enough for effective management of ocular infections.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Knapczyk J, Kro Ìwczynski L, Krzck J, Brzeski M, Nirnberg E, Schenk
D, et al. Requirements of chitosan for pharmaceutical and biomedical
applications. In: Skak-Braek G, Anthonsen T, Sandford P, editors. Chitin
and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties
and Applications. London: Elsevier; 1989. p. 657-63
Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the
permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm
Res 1994;11:1358-61.
De Campos AM, Diebold Y, Carvalho EL, Sánchez A, Alonso MJ. Chitosan
nanoparticles as new ocular drug delivery systems: In vitro Stability, in
vivo fate, and cellular toxicity. Pharm Res 2004;21:803-10.
EnrÃquez de Salamanca A, Diebold Y, Calonge M, GarcÃa-Vazquez C,
Callejo S, Vila A, et al. Chitosan nanoparticles as a potential drug delivery
system for the ocular surface: Toxicity, uptake mechanism and in vivo
tolerance. Invest Ophthalmol Vis Sci 2006;47:1416-25.
Lurui Qin Zhu Wall. Levofloxacin chitosan nanoparticles in rabbit's eyes.
Pharm Clin Res 2007;15:1.
Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated
nanocapsules as ocular drug carriers. Int J Pharm 1997;53:41-50.
Yadav KS, Sathish CS, Shivkumar HG. Preparation and evaluation of
chitosan -Poly (Acrylic acid) Hydrogels as stomach specific delivery
for amoxicillin and metronidazole. Indian J Pharm Sci 2007;69:91-5
Alonso MJ, Sanchez A. Biodegradable nanoparticles as new transmucosal drug carrier. Carrier Based Drug Delivery 2004;879:283-95.
Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. Invitro evaluation of
mucoadhesive properties of chitosan and some other natural polymers.
Int J Pharm 1992;78:43-8.
Feltt O, Buri P, Gurny R. Chitosan; a unique polysaccharide for drug
delivery. Drug Dev Ind Pharm 1998;24:979-93.
Desai MP, Labhasetwar V, Amidon GL Levy RJ. Gastrointestinal uptake
of biodegradable microparticles: Effect of particle size. Pharmacol Res
;13:1838-45.
Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic
chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl
Polm Sci 1997b;63:125-32.
Mosqueira VC, Legrand P, Gref R, Barratt G. In-vitro release kinetic
studies of PEG-modified nanocapsules and nanospheres loaded
with a lipophilic drug: Halofantrine base. Control Rel Bioact Mater
;26:1074-5.
Mosqueira VC, Legrand P, Pinto-Alphandary H, Puisieux F, Barratt G. Poly(D, L-lactide) nanocapsules prepared by a solvent displacement process:Influence of the composition on physicochemical and structural
properties. J Pharm Sci 2000;89:614-26.
Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a
novel delivery system for ammonium glycyrrhizinate. Int J Pharm
;295:235-45.
De Campos M, Sanchez A, Alonso MJ. Chitosan nanoparticles: A new
vehicle for the improvement of the delivery of drugs to the ocular
surface. Application to cyclosporin A. Int J Pharm 2001;224:159-68.
Zhou SB, Deng XM, Li X. Investigation on a novel core-coated
microspheres protein delivery system. J Control Release 2001;75:27-36.
Lehr CM, Bouwstra JA, Schacht E, Junginger HE. In vitro evaluation of
mucoadhesive properties of chitosan and some other natural polymers.
Int J Pharm 1992;78:43-8.
Gundu ZK, O Zdemir O. Topical cyclosporine treatment of
keratoconjunctivitis sicca in secondary Sjogren's syndrome. Acta
Ophthalmol 1994;72:438-42.